Age and laterality of children should be considered when determining IOL power

Article

A child's age and laterality are important factors to consider when determining intraocular lens (IOL) power.

A study featured in the British Journal of Ophthalmology has shown that a child's age and laterality are important factors to consider when determining intraocular lens (IOL) power.

A team lead by Dr R. Wolfs, Erasmus University Medical Center, Department of Ophthalmology, The Netherlands, investigated the amount of myopic shift in children after catract surgery with IOL implantation. The children were split into three groups according to their age. Group A consisted of 0–1 year olds, Group B, 1–7 year olds and Group C, 7–18 year olds. Expected myopic shift was calculated using a formula created by multiple regression analysis. Variables linked with a higher prediction area were also calculated.

Children aged 12 months and under presented with higher myopic shifts and a bigger mean rate of refractive change per year. Higher myopic shifts were also found in children with unilateral cataract. Group A experienced a significantly higher absolute prediction error compared to Group B and Group C.

The results demonstrate that predicting the postoperative refraction in children under 1 years old is complex and factors such as age and laterality need to be considered.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.